相似文献/References:
[1]黄清杰,李茂星,刘 雄△.中医治疗药物性肝损伤研究进展[J].西部中医药,2012,25(07):124.
HUANG Qing-jie,LI Mao-xing,LIU Xiong.Progress of Study on Treatment of Drug-induced Liver Injury with TCM[J].Western Journal of Traditional Chinese Medicine,2012,25(01):124.
[2]吕培,何红彦,曹红涛,等.冬虫夏草制剂对抗结核药物致肝肾损伤的“减毒”作用及其机制[J].西部中医药,2020,33(03):16.[doi:10.12174/j.issn.1004-6852.2020.03.05]
LYU Pei,HE Hongyan,CAO Hongtao,et al.The "Attenuation" Actions and the Mechanism of Dongchong Xiacao Preparation on Liver and Kidney Injury of Antituberculosis Drugs[J].Western Journal of Traditional Chinese Medicine,2020,33(01):16.[doi:10.12174/j.issn.1004-6852.2020.03.05]
[3]李艳,刘丽丽,杨小军,等.慢性乙型肝炎肝郁脾虚证患者中医证候及实验室指标特征观察[J].西部中医药,2022,35(03):72.[doi:10.12174/j.issn.2096-9600.2022.03.17]
LI Yan,LIU Lili,YANG Xiaojun,et al.Observation on the Characteristics of TCM Syndromes and Lab Indicators of Patients with Chronic Hepatitis B of Liver Depression and Spleen Deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2022,35(01):72.[doi:10.12174/j.issn.2096-9600.2022.03.17]
[4]吕超,石清兰,覃倩,等.藏、维两族常用保肝药物研究进展[J].西部中医药,2021,34(07):153.[doi:10.12174/j.issn.2096-9600.2021.07.39]
LYU Chao,SHI Qinglan,QIN Qian,et al.Advances in Research on Common Liver Protective Drugs Used in Tibetan and Uygur[J].Western Journal of Traditional Chinese Medicine,2021,34(01):153.[doi:10.12174/j.issn.2096-9600.2021.07.39]